no arguments if they have an increase in revenue... cash is king.
in the mean time they are saying that they are intending to reduce the bleed by $200K a quarter ostensibly from wages and consultants. so annualised that is a reduction of $800K for the year.
in 2023 (from annual report) they spent $741K odd on employee and director costs, $162K on consultants and contractors and $224K on admin costs.
do they intend to claw $800K back from those 3 items? or is the clawback only intended for a single quarter? (cos maybe an order is coming?)
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
no arguments if they have an increase in revenue... cash is...
Featured News
Add HCD (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.426M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 3780483 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 2023844 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 3780483 | 0.003 |
5 | 4600333 | 0.002 |
6 | 7100000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 2023844 | 3 |
0.005 | 7377055 | 5 |
0.006 | 1053873 | 3 |
0.008 | 130587 | 1 |
0.010 | 456400 | 2 |
Last trade - 16.12pm 06/05/2024 (20 minute delay) ? |
Featured News
HCD (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online